Results 21 to 30 of about 3,143 (204)

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal

open access: yesFrontiers in Neurology, 2021
Fingolimod (FTY) is a disease modifying therapy for relapsing remitting multiple sclerosis (RRMS) which can lead to severe lymphopenia requiring therapy discontinuation in order to avoid adverse events.
Valeria Koska   +8 more
doaj   +1 more source

Tumefactive: A Rare First presentation of Multiple Sclerosis [PDF]

open access: yesDisease and Diagnosis, 2018
Tumefactive demyelinating lesions are a rare presentation of multiple sclerosis (MS). Diagnosis of tumefactive is commonly carried out using magnetic resonance image (MRI). Tumefactive diagnosis is difficult because of may similar to the clinical and MRI
Athena Sharifi Razavi   +3 more
doaj   +1 more source

Tumefactive demyelinating lesion [PDF]

open access: yesNeurology, 2007
A previously healthy 31-year-old woman presented with a 2-week history of progressive left hemiparesis. MRI (figure) demonstrated a 3 cm enhancing mass in the right posterior frontal white matter with several smaller lesions in …
Mathew R, Guilfoyle, Ramez W, Kirollos
openaire   +2 more sources

A case of recurrent tumefactive demyelination or tumefactive multiple sclerosis

open access: yesSri Lanka Journal of Child Health, 2021
No abstract availableSri Lanka Journal of Child Health, 2021: 50(2): 342 ...
Sachin Damke   +2 more
openaire   +2 more sources

Diagnostic Dilemma: An Atypical Case of Astrocytoma in a Patient with Relapsing–Remitting Multiple Sclerosis

open access: yesNeurology International, 2021
Distinguishing between tumefactive demyelinating lesions (TDLs) and brain tumors in multiple sclerosis (MS) can be challenging. A progressive course is highly common with brain tumors in MS and no single neuroimaging technique is foolproof when ...
Chantal Kahovec   +2 more
doaj   +1 more source

Non-Syndromic Tumefactive Demyelinating Lesions in the Pediatric Population: Four Case Reports and Review of the Literature. [PDF]

open access: yesAnn Child Neurol Soc
ABSTRACT Introduction Tumefactive demyelinating lesions (TDLs) are large lesions (> 2 cm) seen in demyelinating syndromes such as multiple sclerosis, myelin oligodendrocyte glycoprotein antibody‐associated disorder, and neuromyelitis optica spectrum disorder. They rarely occur in children and most often have a monophasic course.
Ballinger EC   +6 more
europepmc   +2 more sources

Spontaneous regression of asymptomatic tumefactive perivascular spaces in the anterior temporal lobe [PDF]

open access: yes, 2022
Perivascular spaces are fluid-filled spaces that surround the perforating vessels of the brain and are normal findings on brain imaging. These are usually asymptomatic and are considered a manifestation of aging.
Nagashima, Yoshitaka   +6 more
core   +1 more source

Ring-enhancing tumefactive multiple sclerosis

open access: yes, 2023
Multiple sclerosis (MS) is an inflammatory disorder characterised by the demyelination of axons producing plaques in the brain and spinal cord. The pattern of inflammation follows a relapsing course punctuated by periods of remyelination, with symptoms ...
Yoshihiro Katsuura (9139133)
core   +3 more sources

A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome [PDF]

open access: yes, 2014
r.
Kelly Pegoretti Baruteau   +14 more
core   +2 more sources

Magnetic-Resonance Diffusion-Tensor Tractography in the Diagnosis of Tumefactive Spinal-Cord Lesions in Neuromyelitis Optica

open access: yesDiagnostics, 2020
Magnetic-resonance (MR) imaging is the modality of choice for the evaluation of spinal-cord lesions. However, challenges persist in discriminating demyelinating processes from neoplastic lesions using conventional MR sequences.
Yung Hsu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy